Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H. Uhm, Kurt A. Jaeckle, Jan C. Buckner et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 186
Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).Frank A. Sinicrope, Jeffrey A. Meyerhardt, Christopher H. Lieu et al.|Journal of Clinical Oncology|2025Cited by 47